Nanoparticle T cell engagers for the treatment of acute myeloid leukemia https://t.co/Whsi8iyn3p https://t.co/81cCLlkMxV
New article: Nanoparticle T cell engagers for the treatment of acute myeloid leukemia https://t.co/opxqUd0AL6 #AML #leusm #hematology https://t.co/B5vbLC6v0x
RT @Oncotarget: Researchers from @WUSTLmed and @WashUengineers wrote Oncotarget's cover paper this week: "Nanoparticle T cell engagers for…
Researchers from @WUSTLmed and @WashUengineers wrote Oncotarget's cover paper this week: "Nanoparticle T cell engagers for the treatment of acute myeloid leukemia." Read the full study: https://t.co/NU4sW4bjH9 #acutemyeloidleukemia https://t.co/21CW1ehYCT
The #PaperoftheDay is from the cover of Oncotarget's latest issue of publications: "Nanoparticle T cell engagers for the treatment of acute myeloid leukemia" https://t.co/NU4sW4bjH9 #AML #leukemia #cancer #nanotechnology #oncology #publication #research #m
RT @Oncotarget: The cover of Oncotarget's latest issue features Figure 4, "Efficacy of nanoTCEs in vivo," by Alhallak, et al. https://t.co/…
RT @Oncotarget: The cover of Oncotarget's latest issue features Figure 4, "Efficacy of nanoTCEs in vivo," by Alhallak, et al. https://t.co/…
RT @Oncotarget: The cover of Oncotarget's latest issue features Figure 4, "Efficacy of nanoTCEs in vivo," by Alhallak, et al. https://t.co/…
RT @Oncotarget: The cover of Oncotarget's latest issue features Figure 4, "Efficacy of nanoTCEs in vivo," by Alhallak, et al. https://t.co/…